Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · IEX Real-Time Price · USD
19.92
+0.98 (5.17%)
At close: Jul 19, 2024, 4:00 PM
19.99
+0.07 (0.35%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $549.94 million as of July 22, 2024. Its market cap has increased by 55.13% in one year.
Market Cap
549.94M
Enterprise Value
335.78M
1-Year Change
55.13%
Ranking
Category
Stock Price
$19.92
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $330.80M to $549.94M, an increase of 66.24%. That is a compound annual growth rate of 10.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 549.90M | -5.30% |
| Dec 29, 2023 | 580.70M | -6.38% |
| Dec 30, 2022 | 620.30M | -42.81% |
| Dec 31, 2021 | 1.08B | -18.88% |
| Dec 31, 2020 | 1.34B | 127.85% |
| Dec 31, 2019 | 586.80M | 77.39% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iTeos Therapeutics | 568.21M |
| Alector | 561.92M |
| National Research | 561.83M |
| Mind Medicine (MindMed) | 559.07M |
| Quanterix | 551.09M |
| Terns Pharmaceuticals | 548.79M |
| Neurogene | 548.55M |
| LENZ Therapeutics | 547.72M |